Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The P681H Mutation in the Spike Glycoprotein of the Alpha Variant of SARS-CoV-2 Escapes IFITM Restriction and Is Necessary for Type I Interferon Resistance
María José Lista, Helena Winstone, Harry Wilson, et al.
Journal of Virology (2022) Vol. 96, Iss. 23
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Omicron: What Makes the Latest SARS-CoV-2 Variant of Concern So Concerning?
Christoph Jung, Dorota Kmieć, Lennart Koepke, et al.
Journal of Virology (2022) Vol. 96, Iss. 6
Open Access | Times Cited: 202
SARS-CoV-2: Evolution and Emergence of New Viral Variants
Verónica Roxana Flores-Vega, Jessica Viridiana Monroy-Molina, Luis Enrique Jiménez-Hernández, et al.
Viruses (2022) Vol. 14, Iss. 4, pp. 653-653
Open Access | Times Cited: 85
SARS-CoV-2 and innate immunity: the good, the bad, and the “goldilocks”
Benjamín L. Sievers, Mark T. K. Cheng, Kata Csiba, et al.
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 2, pp. 171-183
Open Access | Times Cited: 44
Phenotypic evolution of SARS-CoV-2 spike during the COVID-19 pandemic
Wilhelm Furnon, Vanessa M. Cowton, Giuditta De Lorenzo, et al.
Nature Microbiology (2025)
Open Access | Times Cited: 1
SARS-CoV-2 evolution influences GBP and IFITM sensitivity
Dejan Mesner, Ann‐Kathrin Reuschl, Matthew Whelan, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 5
Open Access | Times Cited: 35
Interferon‐induced transmembrane protein 3 (IFITM3) limits lethality of SARS‐CoV‐2 in mice
Adam D. Kenney, Ashley Zani, Jeffrey Kawahara, et al.
EMBO Reports (2023) Vol. 24, Iss. 4
Open Access | Times Cited: 30
Molecular Evolution of SARS-CoV-2 during the COVID-19 Pandemic
Luis Daniel González-Vázquez, Miguel Arenas
Genes (2023) Vol. 14, Iss. 2, pp. 407-407
Open Access | Times Cited: 27
CRISPR‐Cas system: A promising tool for rapid detection of SARS‐CoV‐2 variants
Jing Li, Kuo Zhang, Guigao Lin, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 1
Closed Access | Times Cited: 7
SARS-CoV-2 Variants of Concern Hijack IFITM2 for Efficient Replication in Human Lung Cells
Rayhane Nchioua, Annika Schundner, Dorota Kmieć, et al.
Journal of Virology (2022) Vol. 96, Iss. 11
Open Access | Times Cited: 31
The antiviral state of the cell: lessons from SARS-CoV-2
Jérémie Le Pen, Charles M. Rice
Current Opinion in Immunology (2024) Vol. 87, pp. 102426-102426
Closed Access | Times Cited: 5
Structural and functional properties of the SARS-CoV-2 spike protein: Potential vaccine and drug development for COVID-19
Reed L. Berkowitz, David A. Ostrov
Elsevier eBooks (2025), pp. 57-74
Closed Access
Dissecting the COVID‐19 Immune Response: Unraveling the Pathways of Innate Sensing and Response to SARS‐CoV‐2 Structural Proteins
María Guadalupe Vizoso-Pinto, Leonardo de Paula Pereira, Ana Luiza Pessoa de Mendonça Angelo, et al.
Journal of Molecular Recognition (2025) Vol. 38, Iss. 2
Closed Access
Epidemiology and Characteristics of SARS-CoV-2 Variants of Concern: The Impacts of the Spike Mutations
Théophile Cocherie, Karen Zafilaza, Valentin Leducq, et al.
Microorganisms (2022) Vol. 11, Iss. 1, pp. 30-30
Open Access | Times Cited: 22
The effects of amino acid substitution of spike protein and genomic recombination on the evolution of SARS-CoV-2
Letian Fang, Jie Xu, Yue Zhao, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 13
Therapeutic development targeting host heparan sulfate proteoglycan in SARS-CoV-2 infection
Qi Zhang, Ivan Pavlinov, Yihong Ye, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 4
Role of Viral Envelope Proteins in Determining Susceptibility of Viruses to IFITM Proteins
Thomas E. Marceau, Martine Braibant
Viruses (2024) Vol. 16, Iss. 2, pp. 254-254
Open Access | Times Cited: 3
COVID-19 genome surveillance: A geographical landscape and mutational mapping of SARS-CoV-2 variants in central India over two years
Krishna Khairnar, Siddharth Singh Tomar
Virus Research (2024) Vol. 344, pp. 199365-199365
Open Access | Times Cited: 3
Comparing the evolutionary dynamics of predominant SARS-CoV-2 virus lineages co-circulating in Mexico
Hugo G. Castelán‐Sánchez, Luis Delaye, Rhys P. D. Inward, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 9
High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1
William Bolland, Vincent Michel, Delphine Planas, et al.
Journal of Virology (2023) Vol. 98, Iss. 1
Open Access | Times Cited: 8
Within-host evolution of SARS-CoV-2: how often are de novo mutations transmitted from symptomatic infections?
Chapin S. Korosec, Lindi M. Wahl, Jane M. Heffernan
Virus Evolution (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Antibodies utilizing VL6-57 light chains target a convergent cryptic epitope on SARS-CoV-2 spike protein and potentially drive the genesis of Omicron variants
Qihong Yan, Xijie Gao, Banghui Liu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
A genome-wide arrayed CRISPR screen identifies PLSCR1 as an intrinsic barrier to SARS-CoV-2 entry that recent virus variants have evolved to resist
Jérémie Le Pen, Gabrielle Paniccia, Volker Kinast, et al.
PLoS Biology (2024) Vol. 22, Iss. 9, pp. e3002767-e3002767
Open Access | Times Cited: 2
Inferring selection effects in SARS-CoV-2 with Bayesian Viral Allele Selection
Martin Jankowiak, Fritz Obermeyer, Jacob E. Lemieux
PLoS Genetics (2022) Vol. 18, Iss. 12, pp. e1010540-e1010540
Open Access | Times Cited: 12
A Noncoding A-to-U Kozak Site Change Related to the High Transmissibility of Alpha, Delta, and Omicron VOCs
Jianing Yang, Y.X. Cui, Dalang Yu, et al.
Molecular Biology and Evolution (2023) Vol. 40, Iss. 6
Open Access | Times Cited: 6
The Key Site Variation and Immune Challenges in SARS-CoV-2 Evolution
Ying Liu, Qing Ye
Vaccines (2023) Vol. 11, Iss. 9, pp. 1472-1472
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top